Enveda appoints Vanitha Sekar as Chief Business Officer
She joins Enveda from Gilead Sciences
She joins Enveda from Gilead Sciences
Advancing to IND-enabling studies with multiple drug candidates
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Novavax’ clinical development program reported no severe allergic reactions
Plant is part of the company's CAD $30 million capital investment in the site
MINYM can be safely used by patients above 9 years of age.
Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity
The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics
Subscribe To Our Newsletter & Stay Updated